148 related articles for article (PubMed ID: 29806630)
1. Serum Levels of TRIM72 Are Lower among Patients with Colon Cancer: Identification of a Potential Diagnostic Marker.
Chen Z; Yin X; Li K; Chen S; Li H; Li Y; Zhang Q; Wang H; Qiu Y
Tohoku J Exp Med; 2018 May; 245(1):61-68. PubMed ID: 29806630
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1.
Attallah AM; El-Far M; Ibrahim AR; El-Desouky MA; Omran MM; Elbendary MS; Attallah KA; Qura ER; Abdallah SO
Br J Biomed Sci; 2018 Jul; 75(3):122-127. PubMed ID: 29734875
[TBL] [Abstract][Full Text] [Related]
3. Zinc-α-2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population.
Xue Y; Yu F; Yan D; Cui F; Tang H; Wang X; Chen J; Lu H; Zhao S; Peng Z
Int J Mol Sci; 2014 Dec; 16(1):691-703. PubMed ID: 25561225
[TBL] [Abstract][Full Text] [Related]
4. TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma.
Fernández-Aceñero MJ; Cruz M; Sastre-Varela J; Casal JI; Nieto MAC; Del Puerto-Nevado L; García-Foncillas J; Cebrián A
Pathol Oncol Res; 2020 Apr; 26(2):861-865. PubMed ID: 30852740
[TBL] [Abstract][Full Text] [Related]
5. Combination of serum lipids and cancer antigens as a novel marker for colon cancer diagnosis.
Li T; Qian Y; Li H; Deng J
Lipids Health Dis; 2018 Nov; 17(1):261. PubMed ID: 30458796
[TBL] [Abstract][Full Text] [Related]
6. Toward standardized high-throughput serum diagnostics: multiplex-protein array identifies IL-8 and VEGF as serum markers for colon cancer.
Bünger S; Haug U; Kelly FM; Klempt-Giessing K; Cartwright A; Posorski N; Dibbelt L; Fitzgerald SP; Bruch HP; Roblick UJ; von Eggeling F; Brenner H; Habermann JK;
J Biomol Screen; 2011 Oct; 16(9):1018-26. PubMed ID: 21807963
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
8. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of serum microRNA-135a-5p level in colorectal cancer].
Wang QJ; Zhang HC; Shen XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):909-914. PubMed ID: 27998467
[No Abstract] [Full Text] [Related]
12. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum ELAM-1 and metastasis among patients with colon cancer.
Takahashi Y; Mai M; Watanabe M; Tokiwa M; Nishioka K
Dis Colon Rectum; 1998 Jun; 41(6):770-4. PubMed ID: 9645747
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
16. Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients.
Chen Z; Li K; Yin X; Li H; Li Y; Zhang Q; Wang H; Qiu Y
J Cancer; 2019; 10(5):1288-1296. PubMed ID: 30854138
[TBL] [Abstract][Full Text] [Related]
17. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
18. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
Carpelan-Holmström MA; Haglund CH; Roberts PJ
Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374
[TBL] [Abstract][Full Text] [Related]
19. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
